Two distinct dendritic cell (DC) subsets, conventional DCs (cDCs) and plasmacytoid DCs (pDCs) have been shown to develop via either the myeloid or the lymphoid pathway in murine hematopoiesis. Lineage-specific phenotypes or functions of "myeloid" and "lymphoid" DCs, however, still remain elusive. Furthermore, such analysis has been particularly difficult in humans, due to lack of an assay system appropriate for the analysis of human stem and progenitor cell differentiation. Here, propose that human DCs use unique and flexible developmental programs that cannot be categorized into the conventional myeloid or lymphoid pathway.
Introduction
Dendritic cells (DCs) play a crucial role in maintaining the immune system 1, 2 . They are particularly efficient in presenting antigenic peptides in the context of MHC to T cells.
Two DC subsets, conventional dendritic cells (cDCs) and plasmacytoid dendritic cells (pDCs), have been identified in murine and human hematopoietic tissues [3] [4] [5] [6] [7] . cDCs are known to initiate primary T cell responses, thereby orchestrating and potentiating the acquired immunity against foreign antigens. pDCs were originally reported as a cell type that is morphologically similar to plasma cells in the T cell zones of human lymphoid organs 8 . In contrast to cDCs, pDCs do not stimulate naïve T cells into cycle, but can be converted into cDC-like cells upon activation and function as efficient APCs 9, 10 . Of note, pDCs but not cDCs, are capable of secreting a large amount of type-I interferons (IFNs) in response to unmethylated CpG oligonucleotides, viral and self nucleic acids 5, 11, 12, 13, 14 . In the context of the T H 1/ T H 2 balance, human pDCs play an essential role in inducing differentiation of T H 2, whereas cDCs preferentially induce a T H 1 response 15 . Each DC subset displays different groups of Toll-like receptors (TLRs)
to effectively sense a wide array of invading pathogens 10 .
Developmental pathways for these human DC subsets, however, still remain enigmatic. cDCs have been shown to develop from monocytes in the presence of IL-4
and GM-CSF, and are sometimes called as "myeloid" DCs. On the other hand, pDCs are often referred to as "lymphoid" DCs mainly because they possess several critical "lymphoid" markers such as the rearrangement of immunoglobulin heavy chain (IgH) D-J 16, 17 and preT cell receptor α (pTα) transcripts 18, 19 . This simple classification proved to be incorrect, given that in murine hematopoiesis, cDCs and pDCs can be generated from either myeloid-or lymphoid-committed bone marrow progenitor populations in vivo and in vitro 17, 20, 21, 22 . Therefore, mature pDCs appear to ectopically activate some genetic programs primarily associated with early lymphocyte development regardless of their lineage origin. In human hematopoiesis, transplantation of hCD34 + human bone marrow or cord blood cells into adult NOD.Cg-Prkdc scid (NOD-scid) or newborn
Rag2
-/-γc -/-mice resulted in the generation of DCs in vivo 23, 24 . The hCD34 + fraction is a heterogeneous population, containing HSCs, common myeloid progenitors (CMPs),
For personal use only. on October 28, 2017 . by guest www.bloodjournal.org From common lymphoid progenitors (CLPs) and a variety of monopotent progenitors. A recent study has shown that purified human CMPs and CLPs can give rise to cDCs and pDCs, at least when cultured in the presence of murine stromal cells and human cytokines 25 . Several critical questions, however, remain to be addressed: It is still unclear whether myeloid and lymphoid pathways contribute to the formation of human cDC or pDC pools in vivo. And if they do, it is unclear whether such DC subsets of myeloid or lymphoid origin are intrinsically different, thereby enabling them to exert distinct functions or display distinct phenotypes. One of the obstacles to address these questions has been the lack of an assay system efficient enough to evaluate lineage potential of committed progenitors in vivo.
We have recently established a highly efficient xenogeneic transplantation system by using newborns of NOD-scid/IL2rγ null mice 26 . This xenotransplant system can recapitulate hematopoietic development from the most primitive hCD34 + hCD38 -long-term human HSC fraction 26 . In the present study, by adoptive transfer of prospectively-purified human hematopoietic progenitors into NOD-scid/IL2rγ null newborns, we found that both cDCs and pDCs are efficiently produced from the human CMP and CLP in vivo, and that each DC subset of CMP or CLP origin shared identical gene expression profiles. Thus, the common human DC developmental program could be activated even after the cells are committed into the myeloid or the lymphoid lineage, resulting in the formation of single human cDC and pDC pools in vivo. These data collectively suggest that the DC developmental program is operated independently of myeloid or lymphoid ones at least in human hematopoiesis. 
Materials and Methods

.
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NOD.Cg-Prkdc
Microarray analysis
Complementary RNA (cRNA) with biotin16-UTP (Roche diagnostics, Basel, Switzerland) for hybridization with Illumina Sentrix® arrays was prepared using the Illumina® TotalPrep RNA amplification kit (Ambion, Austin, TX). Briefly, reverse transcription to synthesize first strand cDNA was primed with the T7 oligo (dT) primer to synthesize cDNA containing a T7 promoter sequence. Single-stranded cDNA was then incubated with DNA polymerase and RNase H to simultaneously degrade the RNA and synthesize second strand cDNA. After purification, double-stranded cDNA was subject to in vitro transcription to synthesize multiple copies of biotinylated cRNA.
Amplified cRNA was purified and verified by a spectrophotometer and an agarose-gel electrophoresis. Subsequently, cRNA (1. 
Microarray data analysis
Illumina beads station was used as the first tool for data analysis. This software allows for calculation of the signal intensity and determination of whether each probe set is present. The signal intensity was then normalized both per chip and per gene using 
Results
Human HSCs can generate cDCs and pDCs in NOD-scid/IL2rγ null mouse
We first tested whether human HSCs can develop cDCs and pDCs together with other blood cells in our xenogeneic transplantation system 26 Figure 1C ). HSC-derived cDCs and pDCs were phenotypically isolatable by FACS ( Figure 1D ). Purified pDCs but not cDCs had basal levels of IFNα2 and β1
mRNA, and treatment with unmethylated CpG oligonucleotides induced significant up-regulation of IFN mRNAs only in pDCs ( Figure 1E ), suggesting that the xenotransplant system supports the functional maturation of at least the pDC subset.
Human myeloid and lymphoid progenitors can give rise to both cDCs and pDCs
We wished to evaluate whether myeloid or lymphoid pathways can contribute to the DC pool formation in vivo. CMPs and CLPs were purified from 4 normal human cord blood, On the other hand, in all CLP recipients, percentages of hCD45 + cells were ~4% in the bone marrow and ~2% in the spleen at 4 weeks post transplantation. Human CLPs ( Figure 3A ) differentiated into B and NK cells in the spleen, whereas T cells were found almost exclusively in the thymus at this time point ( Figure 3B ). In the bone marrow, cDCs and pDCs constituted 10.7% and 11.2% of hCD45 + cells in average of four independent experiments, respectively ( Figure 3C ). In the spleen, cDCs and pDCs accounted for 13.8% and 9.0% of hCD45 + cells, respectively. Measurable levels of DCs were not found in the thymus of recipients transplanted with CMPs or CLPs.
Together, these data provide formal proof that, as in the case of murine hematopoiesis 17, [20] [21] [22] , both human myeloid and lymphoid pathways can contribute to generation of cDCs and pDCs in vivo.
Each DC subset displays similar expression profiles of representative surface antigens and genes, regardless of their lineage origin
We then evaluated the expression patterns of DC-related antigens in these DC subsets generated from either the myeloid or the lymphoid lineage in vivo. DCs express various co-stimulatory molecules such as hCD40, hCD80, hCD83, and hCD86 together with MHC antigens, all of which are crucial for efficient activation of T cells 1 . As
shown in Figures 4A and 4B , both cDCs and pDCs expressed hCD86, but not hCD40, hCD80 (data not shown) or hCD83 (data not shown), suggesting an immature phenotype of these DCs. BDCA-2, a marker specific for human pDC 34 , was expressed only in pDCs, while TLR2 was expressed in cDCs but not in pDCs 10 . The expression patterns of these molecules were well preserved in both DC subsets regardless of their lineage origin.
We further tested the level of DC-related transcripts in cDCs and pDCs by real-time PCR assays. Figure 4C shows the relative mRNA levels of representative genes between cDCs and pDCs purified from bone marrow of normal human volunteers, and of mice reconstituted with human CMPs or CLPs. Genes tested included TLRs (TLR2, TLR4, TLR7, TLR9), transcription factors (SpiB, PU.1, Id2 and Notch1), and pTα.
Consistent with the FACS data ( Figures 4A and 4B ), TLR2 mRNA was expressed at a higher level in cDCs. TLR4 was also expressed strongly in cDCs. pDCs are known to selectively express TLR7 and TLR9, which are normally expressed in the cellular endosomes 10, 35 . SpiB, an Ets family member, is a key regulator of pDC development, because SpiB knockdown in human CD34 + progenitor cells compromises their development into pDCs 36 . PU.1, another Ets-family transcription factor, is required for development of cDC and CD14 + myeloid cells 37 . In either mice reconstituted with CMPs or CLPs, SpiB and PU.1 are expressed at a higher level in pDCs and cDCs, respectively ( Figure 4C ). Lymphoid-related Notch1 and pTα was expressed in pDCs irrespective of their origin. It should be noted that the expression patterns of these genes in DC subsets generated in the NOD-scid/IL2rγ null xenotransplant system were consistently observed in DC subsets purified directly from human bone marrow ( Figure   4C ).
Taken together, these findings suggest that DC subsets exhibit similar phenotypic and transcriptional characteristics regardless of their CMP or CLP origin. In addition, the similar gene expression pattern in human DC subsets developing in the NOD-scid/IL2rγ null and the human bone marrow suggests that NOD-scid/IL2rγ null bone marrow provides the proper microenvironment that allows human progenitors to recapitulate normal differentiation and maturation into the DC lineage.
Each DC subset possesses an identical transcriptional profile irrespective of their lineage origin even at the genome-wide level
The fact that each DC subset possessed similar expression patterns of representative genes related to DC functions urged us to overview their mRNA expression at the genome-wide level by using a cDNA microarray. 10 4 cells of each DC subset purified from mice reconstituted with human CMPs or CLPs were subjected to this analysis. Figure 5A shows scatter plots of the signal intensity of 48,000 transcripts.
Signal intensity for each gene was scanned, normalized, and plotted to evaluate the correlation between the 2 groups. Strikingly, the difference of signal intensity of each gene was marginal between CMP-and CLP-derived pDCs (i), and between CMP-and CLP-derived cDCs (ii) (the correlation coefficient (r) = 0.98 and 0.95, respectively). In contrast, the same analysis between CMP-derived cDC and pDCs (iii), or between CLP-derived cDCs and pDCs (iv) showed that a substantial number of genes exhibited dissociated signal intensities (r= 0.917 and 0.925, respectively). These data again suggest that the lineage origin does not affect the transcriptional profile of each DC subset.
We then focused the analysis on a subset of 218 genes that displayed more than 3-fold differences between cDCs and pDCs of each lineage origin. Figure 5B shows the . Thus, previous studies subclassified each DC subset into myeloid and lymphoid, and have tried to find subclass-specific phenotypes and functions 17, 20, 21, 22, 23 .
Such analysis has been difficult, however, particularly in human hematopoiesis at least due to lack of a reliable in vivo assay system. human DC subsets obtained in this xenogeneic system was quite similar to that of primary DC subsets purified from normal, steady-state human bone marrow ( Figure 4C ).
To test the functional maturation of human cDCs generated in our system, we purified CMP-or CLP-derived cDCs, and cultured with allogeneic T cells from the blood in adults in vitro for 7 days. In either case, allogeneic T cells displayed a significant proliferation estimated by 3 H-thymidine incorporation 38 only in the presence of donor-derived cDCs (data not shown), suggesting that both myeloid and lymphoid cDCs developed in the xenogeneic system are capable of presenting alloantigens to T cells. Together, these data suggest that the NOD-scid/IL2rγ null bone marrow provides the proper microenvironment for human progenitors to recapitulate human DC development machinery in the bone marrow. Collectively, human myeloid and lymphoid pathways might naturally give rise to equivalent DC subsets in vivo. The proposed developmental path of DCs is schematized in Figure 7 .
Previous papers have shown that the CMP, as a population, has minor B cell potential 39, 40 . In fact, in our experiments, injection of 10 4 CMPs resulted in generation of a few percent of CD19 + B cells in the spleen (data not shown). Such B cell potential is likely to be derived from rare proB cells sharing the phenotype with the CMP population but not from CLP contaminants, because T or NK cell differentiation from CMPs has not been observed in mouse 40 or human hematopoiesis 39 . Furthermore, B
cell-committed precursors including proB and preB cells do not give rise to dendritic cells in mouse 17 and in human (our unpublished data). DC development from the CMP might occur in association with myeloid but not with their minor B cell development, and therefore, at least the vast majority of human CMP-derived DCs in our experiments should be categorized into the myeloid lineage.
Although DCs were originally defined as myeloid cells, the alternative lymphoid origin for DCs was demonstrated in murine hematopoiesis by the fact that early thymocyte progenitors are capable of generating CD8α + cDCs in vivo 41, 42 . This important finding was further strengthened by the fact that mice deficient for the myeloid transcription factors, RelB 43 
